Bern, Switzerland

Regula Styger

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Regula Styger: Innovator in Pharmaceutical Stability

Introduction

Regula Styger is a prominent inventor based in Bern, Switzerland, known for her contributions to the field of pharmaceuticals. With a total of three patents to her name, she has made significant advancements in the stability of immunoglobulin preparations.

Latest Patents

Her latest patents include a pharmaceutical product with increased stability comprising immunoglobulins. This invention pertains to a polyclonal immunoglobulin solution in a pre-filled polymer syringe, which is packaged with an oxygen scavenger to enhance stability. Another notable patent focuses on immunoglobulin preparations having increased stability, which involves a protein preparation that includes a stabilizer selected from non-polar and basic amino acids, maintaining a pH of 4.0 to 5.2. This invention also relates to a pharmaceutical composition and a method for stabilizing protein preparations.

Career Highlights

Throughout her career, Regula Styger has worked with reputable companies such as CSL Behring AG and ZLB Behring AG. Her work in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Regula has collaborated with notable professionals in her field, including Reinhard Franz Bolli and Gerhard Hodler. These collaborations have further enriched her research and development efforts.

Conclusion

Regula Styger's innovative work in the pharmaceutical industry, particularly in enhancing the stability of immunoglobulin preparations, showcases her significant contributions to science and medicine. Her patents reflect her dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…